{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T05:13:21Z","timestamp":1788585201198,"version":"build-2803163510"},"reference-count":56,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>In the metabolic pathways associated with major biogenic amines, such as dopamine, noradrenaline, and serotonin, there exists a group of compounds known as trace amines. These trace amines share structural similarities with the major biogenic amines. Since the discovery of trace amine-associated receptors (TAARs) that are activated by trace amines, numerous studies have suggested that these receptors, particularly the TAAR1 subfamily, play a role in modulating the stress response and are involved in stress-related psychiatric disorders, including depression, bipolar disorder, and anxiety. Research indicates that TAAR1 regulates the release of neurotransmitters like dopamine and serotonin, which may be a potential mechanism underlying the involvement of trace amines and TAAR1 in response to stress. Several selective TAAR1 agonists have been evaluated in various animal models of depression and anxiety, showing that these compounds can be effective in alleviating depressive and anxiety-like behaviors. Additionally, TAAR5 has also been found to have an effect on anxiety; it is proposed that a TAAR5 antagonist might produce anxiolytic effects. Despite our limited understanding of the underlying mechanisms through which TAARs regulates stress-related disorders, current evidence strongly suggests that TAAR ligands could represent novel pharmacotherapy for treating psychiatric disorders such as depression, bipolar disorder, and anxiety disorders like post-traumatic stress disorder (PTSD). This offers hope for more effective and safer treatment options in the field of mental health.<\/jats:p>","DOI":"10.3389\/fphar.2025.1598048","type":"journal-article","created":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T05:24:32Z","timestamp":1745558672000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Trace amine-associated receptors as potential targets for the treatment of anxiety and depression"],"prefix":"10.3389","volume":"16","author":[{"given":"Zelong","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luoting","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinquan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,4,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1038\/sj.mp.4001665","article-title":"A family-based and case-control association study of trace amine receptor genes on chromosome 6q23 in bipolar affective disorder","volume":"10","author":"Abou Jamra","year":"2005","journal-title":"Mol. Psychiatry"},{"key":"B2","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s10571-019-00716-1","article-title":"Putative trace-amine associated receptor 5 (TAAR5) agonist \u03b1-NETA increases electrocorticogram gamma-rhythm in freely moving rats","volume":"40","author":"Belov","year":"2020","journal-title":"Cell Mol. Neurobiol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.pharmthera.2017.07.002","article-title":"Pharmacology of human trace amine-associated receptors: therapeutic opportunities and challenges","volume":"180","author":"Berry","year":"2017","journal-title":"Pharmacol. Ther."},{"key":"B4","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.biopsych.2016.10.012","article-title":"Trace amine-associated receptor 1 agonists as narcolepsy therapeutics","volume":"82","author":"Black","year":"2017","journal-title":"Biol. Psychiatry"},{"key":"B5","doi-asserted-by":"publisher","first-page":"8966","DOI":"10.1073\/pnas.151105198","article-title":"Trace amines: identification of a family of mammalian G protein-coupled receptors","volume":"98","author":"Borowsky","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1124\/mol.60.6.1181","article-title":"Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor","volume":"60","author":"Bunzow","year":"2001","journal-title":"Mol. Pharmacol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/0306-4522(84)90020-4","article-title":"Prenatal ontogenesis of p-m-octopamine and phenylethanolamine in relation to catecholamines and their metabolizing enzymes in the developing rat brain and heart","volume":"12","author":"David","year":"1984","journal-title":"Neuroscience"},{"key":"B8","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/0278-5846(94)90022-1","article-title":"The trace amines and their acidic metabolites in depression--an overview","volume":"18","author":"Davis","year":"1994","journal-title":"Prog. neuro-psychopharmacology and Biol. psychiatry"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1124\/jpet.119.260281","article-title":"SEP-363856, a novel psychotropic agent with a unique, non-D(2) receptor mechanism of action","volume":"371","author":"Dedic","year":"2019","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B10","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0165-1781(84)90034-9","article-title":"Phenylethylamine excretion in depression","volume":"13","author":"DeLisi","year":"1984","journal-title":"Psychiatry Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"108373","DOI":"10.1016\/j.neuropharm.2020.108373","article-title":"Increased dopamine transmission and adult neurogenesis in trace amine-associated receptor 5 (TAAR5) knockout mice","volume":"182","author":"Efimova","year":"2021","journal-title":"Neuropharmacology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3389\/fnmol.2020.00018","article-title":"Trace amine-associated receptor 5 provides olfactory input into limbic brain areas and modulates emotional behaviors and serotonin transmission","volume":"13","author":"Espinoza","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"B13","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1113\/jphysiol.1976.sp011586","article-title":"Octopamine release at two points along lobster nerve trunks","volume":"262","author":"Evans","year":"1976","journal-title":"J. Physiol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/BF01928707","article-title":"Phenethylamine content of human urine and rat brain, its alterations in pathological conditions and after drug administration","volume":"28","author":"Fischer","year":"1972","journal-title":"Experientia."},{"key":"B15","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.euroneuro.2021.10.003","article-title":"Lithium treatment of Bipolar disorder in adults: a systematic review of randomized trials and meta-analyses","volume":"54","author":"Fountoulakis","year":"2022","journal-title":"Eur. Neuropsychopharmacol. J. Eur. Coll. Neuropsychopharmacol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1124\/pr.117.015305","article-title":"Trace amines and their receptors","volume":"70","author":"Gainetdinov","year":"2018","journal-title":"Pharmacol. Rev."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1038\/s41386-019-0386-8","article-title":"Trace amine-associated receptor 1 agonism promotes wakefulness without impairment of cognition in Cynomolgus macaques","volume":"44","author":"Goonawardena","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"B18","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.pharmthera.2007.06.007","article-title":"Trace amine-associated receptor 1-Family archetype or iconoclast?","volume":"116","author":"Grandy","year":"2007","journal-title":"Pharmacol. Ther."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1016\/j.euroneuro.2015.08.011","article-title":"Trace amine-associated receptor 1 activation silences GSK3\u03b2 signaling of TAAR1 and D2R heteromers","volume":"25","author":"Harmeier","year":"2015","journal-title":"Eur. Neuropsychopharmacol. J. Eur. Coll. Neuropsychopharmacol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/0165-1781(82)90009-9","article-title":"Fluctuating high urinary phenylethylamine excretion rates in some bipolar affective disorder patients","volume":"6","author":"Karoum","year":"1982","journal-title":"Psychiatry Res."},{"key":"B21","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/s0091-3057(00)00383-x","article-title":"Effects of beta-phenylethylamine on the hypothalamo-pituitary-adrenal axis in the male rat","volume":"67","author":"Kosa","year":"2000","journal-title":"Pharmacol. Biochem. Behav."},{"key":"B22","doi-asserted-by":"publisher","first-page":"9103","DOI":"10.3390\/ijms21239103","article-title":"2-Phenylethylamine (PEA) ameliorates corticosterone-induced depression-like phenotype via the BDNF\/TrkB\/CREB signaling pathway","volume":"21","author":"Lee","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B23","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1080\/15622975.2024.2429507","article-title":"SEP-363856 attenuates CUMS-induced depression-like behaviours and reverses hippocampal neuronal injuries","volume":"25","author":"Li","year":"2024","journal-title":"world J. Biol. psychiatry official J. World Fed. Soc. Biol. Psychiatry"},{"key":"B24","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/sj.mp.4002037","article-title":"No association of trace amine receptor genes with bipolar disorder","volume":"12","author":"Liu","year":"2007","journal-title":"Mol. Psychiatry"},{"key":"B25","doi-asserted-by":"publisher","first-page":"108580","DOI":"10.1016\/j.pharmthera.2023.108580","article-title":"TAAR1 as an emerging target for the treatment of psychiatric disorders","volume":"253","author":"Liu","year":"2024","journal-title":"Pharmacol. Ther."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1038\/s41380-022-01448-3","article-title":"TAAR1 regulates drug-induced reinstatement of cocaine-seeking via negatively modulating CaMKII\u03b1 activity in the NAc","volume":"27","author":"Liu","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"B27","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/S0140-6736(22)00821-2","article-title":"Complex post-traumatic stress disorder","volume":"400","author":"Maercker","year":"2022","journal-title":"Lancet London, Engl."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1124\/pr.109.001107","article-title":"International Union of Pharmacology. LXXII. Recommendations for trace amine receptor nomenclature","volume":"61","author":"Maguire","year":"2009","journal-title":"Pharmacol. Rev."},{"key":"B29","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1007\/s40263-016-0380-1","article-title":"Therapeutic mechanisms of lithium in bipolar disorder: recent advances and current understanding","volume":"30","author":"Malhi","year":"2016","journal-title":"CNS drugs"},{"key":"B30","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.biopsych.2020.12.008","article-title":"TAAR1-Dependent and -independent actions of tyramine in interaction with glutamate underlie central effects of monoamine oxidase inhibition","volume":"90","author":"Mantas","year":"2021","journal-title":"Biol. Psychiatry"},{"key":"B31","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/s0960-9822(99)80389-3","article-title":"The trace amine tyramine is essential for sensitization to cocaine in Drosophila","volume":"9","author":"McClung","year":"1999","journal-title":"Curr. Biol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/BF00711411","article-title":"Binding sites for brain trace amines","volume":"9","author":"Nguyen","year":"1989","journal-title":"Cell Mol. Neurobiol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.neubiorev.2005.03.018","article-title":"Antidepressant effects assessed using behavior maintained under a differential-reinforcement-of-low-rate (DRL) operant schedule","volume":"29","author":"O'Donnell","year":"2005","journal-title":"Neurosci. Biobehav. Rev."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1126\/science.7063846","article-title":"Excretion of beta-phenethylamine is elevated in humans after profound stress","volume":"215","author":"Paulos","year":"1982","journal-title":"Sci. (New York, N.Y.)"},{"key":"B35","doi-asserted-by":"publisher","first-page":"116236","DOI":"10.1016\/j.bcp.2024.116236","article-title":"Activation of trace amine-associated receptor 1 ameliorates PTSD-like symptoms","volume":"228","author":"Peng","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.neubiorev.2020.12.031","article-title":"Bipolar disorder: an evolutionary psychoneuroimmunological approach","volume":"122","author":"Rantala","year":"2021","journal-title":"Neurosci. Biobehav. Rev."},{"key":"B37","doi-asserted-by":"publisher","first-page":"110555","DOI":"10.1016\/j.pnpbp.2022.110555","article-title":"Trace amine-associated receptor 1 modulates motor hyperactivity, cognition, and anxiety-like behavior in an animal model of ADHD","volume":"117","author":"Raony","year":"2022","journal-title":"Prog. neuro-psychopharmacology and Biol. psychiatry"},{"key":"B38","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.3390\/molecules27092755","article-title":"The potential antidepressant action of duloxetine Co-administered with the TAAR1 receptor agonist SEP-363856 in mice","volume":"27","author":"Ren","year":"2022","journal-title":"Mol. Basel, Switz."},{"key":"B39","doi-asserted-by":"publisher","first-page":"8485","DOI":"10.1073\/pnas.1103029108","article-title":"TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity","volume":"108","author":"Revel","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B40","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.biopsych.2012.05.014","article-title":"Trace amine-associated receptor 1 partial agonism reveals novel paradigm for neuropsychiatric therapeutics","volume":"72","author":"Revel","year":"2012","journal-title":"Biol. Psychiatry"},{"key":"B41","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/mp.2012.57","article-title":"A new perspective for schizophrenia: TAAR1 agonists reveal antipsychotic- and antidepressant-like activity, improve cognition and control body weight","volume":"18","author":"Revel","year":"2013","journal-title":"Mol. Psychiatry"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.3389\/fphar.2019.01027","article-title":"Non-functional trace amine-associated receptor 1 variants in patients with mental disorders","volume":"10","author":"Rutigliano","year":"2019","journal-title":"Front. Pharmacol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1038\/s41386-022-01421-2","article-title":"TAAR1 dependent and independent actions of the potential antipsychotic and dual TAAR1\/5-HT(1A) receptor agonist SEP-383856","volume":"47","author":"Saarinen","year":"2022","journal-title":"Neuropsychopharmacology"},{"key":"B44","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1176\/jnp.8.2.168","article-title":"Sustained antidepressant effect of PEA replacement","volume":"8","author":"Sabelli","year":"1996","journal-title":"J. neuropsychiatry Clin. Neurosci."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1126\/science.6857245","article-title":"Urinary phenyl acetate: a diagnostic test for depression?","volume":"220","author":"Sabelli","year":"1983","journal-title":"Sci. (New York, N.Y.)"},{"key":"B46","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1176\/jnp.7.1.6","article-title":"Phenylethylamine modulation of affect: therapeutic and diagnostic implications","volume":"7","author":"Sabelli","year":"1995","journal-title":"J. neuropsychiatry Clin. Neurosci."},{"key":"B47","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1176\/ajp.131.6.695","article-title":"Phenylethylamine hypothesis of affective behavior","volume":"131","author":"Sabelli","year":"1974","journal-title":"Am. J. psychiatry"},{"key":"B48","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/278357a0","article-title":"Deficient production of tyramine and octopamine in cases of depression","volume":"278","author":"Sandler","year":"1979","journal-title":"Nature"},{"key":"B49","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1007\/s40263-013-0097-3","article-title":"Current place of monoamine oxidase inhibitors in the treatment of depression","volume":"27","author":"Shulman","year":"2013","journal-title":"CNS drugs"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/01.ypg.0000180682.18665.a6","article-title":"No association of the trace amine-associated receptor 6 with bipolar disorder in a northern Swedish population","volume":"16","author":"Venken","year":"2006","journal-title":"Psychiatr. Genet."},{"key":"B51","doi-asserted-by":"publisher","first-page":"e13075","DOI":"10.1111\/adb.13075","article-title":"Activation of trace amine-associated receptor 1 attenuates nicotine withdrawal-related effects","volume":"27","author":"Wu","year":"2022","journal-title":"Addict. Biol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1038\/s41467-023-38180-7","article-title":"Neural mechanism of acute stress regulation by trace aminergic signalling in the lateral habenula in male mice","volume":"14","author":"Yang","year":"2023","journal-title":"Nat. Commun."},{"key":"B53","doi-asserted-by":"publisher","first-page":"396","DOI":"10.25082\/jpbr.2023.01.004","article-title":"TAAR1 as a new target for the treatment of bipolar disorder: anti-manic and anti-depressant activity of the novel agonist PCC0105004","volume":"5","author":"Yu","year":"2024","journal-title":"J. Pharm. Biopharm. Res."},{"key":"B54","doi-asserted-by":"publisher","first-page":"105571","DOI":"10.1016\/j.phrs.2021.105571","article-title":"Role of trace amine-associated receptor 1 in the medial prefrontal cortex in chronic social stress-induced cognitive deficits in mice","volume":"167","author":"Zhang","year":"2021","journal-title":"Pharmacol. Res."},{"key":"B55","doi-asserted-by":"publisher","first-page":"110995","DOI":"10.1016\/j.pnpbp.2024.110995","article-title":"TAAR1 in dentate gyrus is involved in chronic stress-induced impairments in hippocampal plasticity and cognitive function","volume":"132","author":"Zhang","year":"2024","journal-title":"Prog. neuro-psychopharmacology and Biol. psychiatry"},{"key":"B56","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1038\/sj.bjp.0706948","article-title":"Trace amine-associated receptors and their ligands","volume":"149","author":"Zucchi","year":"2006","journal-title":"Br. J. Pharmacol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1598048\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T05:24:32Z","timestamp":1745558672000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1598048\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,25]]},"references-count":56,"alternative-id":["10.3389\/fphar.2025.1598048"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1598048","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,25]]},"article-number":"1598048"}}